EN MÉMOIRE Prof. Jean-Jacques Cassiman


Prof Jean-Jacques Cassiman passed away on August 5 after a long battle against lung cancer. He was 79 years old. With this sad event, we lose a giant in the field. We all know his commitment and realizations within the domain of medical genetics, ranging from the development and implementation of DNA testing in the diagnostic lab and its use for historical and forensic investigations to his strong societal engagement where he fought for more attention for rare and genetic disorders. He has been key for the development of the Belgian Plan for Rare Disorders and was always in the forefront for promoting and advancing our field. 

He had an outspoken role in genetics at the international level. As the secretary-general of the European Society from 1993 to 1999, he professionalized the society and transformed it from a scientific society to a forum that also dealt with societal, legal and ethical aspects of genetics. Via different European projects, he has been a thriving force for the harmonization, validation and standardization in genetic testing. 

From 2010 on, he was the chair of Kom op tegen Kanker. The organization and its societal and political impact have considerably grown during these years.

Jean-Jacques was an excellent communicator and an example for many of us in how to explain in simple words the fascinating complexity of genetics to lay people: “he taught his people everything about DNA”… He was straight, inspiring, not afraid of giving his opinion, made things happen, loved progression but hated delays or postponements, and he had a fine sense of humor… The College for Genetics & Rare Diseases will miss him deeply and we want to express our condolences to his family, friends and all who were very dear to him.

EN MÉMOIRE Prof. Jean-Jacques Cassiman
Aux prix « raisonnables » pour thérapies géniques

Aux prix « raisonnables » pour thérapies géniques

Les thérapies géniques et les médicaments innovants sont de plus en plus nombreux.…

En savoir plus
Le séquençage du génome complet, défis et pistes d'organisation pour la Belgique

Le séquençage du génome complet, défis et pistes d'organisation pour la Belgique

Les techniques de séquençage de l'ADN ne cessent d'évoluer. De plus en plus rapides,…

En savoir plus
Bien plus qu'une lueur d'espoir dans le traitement de la SMA de type 1

Bien plus qu'une lueur d'espoir dans le traitement de la SMA de type 1

L'Amyotrophie Spinale de type 1 est une maladie qui condamne des nourrissons à une…

En savoir plus
Le test NIPT est désormais remboursé

Le test NIPT est désormais remboursé

Une circulaire vient d'être publiée par l'INAMI pour une mise en place officielle du…

En savoir plus
Top